ConCallIQ
Go Pro
APOLLOHOSP Healthcare 14 May 2024

Apollohosp Ltd — Q4 FY24

Apollo Hospitals reported a strong Q4 FY24 with consolidated revenue of INR 4,944 crore (up 15% YoY) and EBITDA of INR 641 crore (up 31% YoY).

bullish high
Compare with...
Revenue ₹4,944 Cr +15%
EBITDA ₹641 Cr +31%
PAT ₹258 Cr
EBITDA Margin
Duration
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

New hospital ramp-up may delay margin recovery

Four new hospitals with 1,500 beds to be operationalized by calendar 2025-26; initial costs could pressure margins.

medium · management_commentary
R

Doctor hiring costs may not yield immediate volume benefits

150 new doctors hired in FY24; full revenue contribution expected only by Q2 FY25, posing near-term margin risk.

medium · analyst_question
R

Inventory rationalization impact on pharmacy distribution

Lower inventory buildup reduced pharmacy distribution sales by ~INR 150 crore in Q4; growth recovery depends on store-level execution.

low · data_observation
R

Competitive pressure in Nashik market

Nashik hospital remains a drag on western region occupancy due to multiple competitors and low-paying patient mix.

low · management_commentary